Clinical Trials Browser

Phase 1 × Brain Neoplasms × Dasatinib × Clear all

NCT02389309 2026-03-09

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Phase 1 Active not recruiting

Brain Neoplasms

NCT00609999 2014-07-16

Ph I Dasatinib + Erlotinib in Recurrent MG

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma